TXG
10x Genomics, Inc.
Stock
$93.50+4.74 (+5.34%)Close Oct 2, 2026
- Operating cash flow, 2025
- $136M
- YoY, 2025
- +1,941.6%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $136M | +1,941.6% |
| 2024 | $6.7M | — |
| 2023 | −$15M | — |
| 2022 | −$34M | — |
| 2021 | −$21M | — |
| 2020 | −$218M | — |
| 2019 | $35M | — |
| 2018 | −$76M | — |
| 2017 | −$11M | — |